| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |